Two prominent examples thereof are the bcr–abl fusion gene which takes a central role in the pathogenesis of chronic myelogenous leukemia [38], as well as NTRK gene fusions occurring in a wide range of tumor types [39]. Here, BCR is linked to chronic myelogenous leukemia, BCR-ABL1 positive.